SUPN
SUPN
NASDAQ · Pharmaceuticals

Supernus Pharmaceuticals Inc

$45.14
+0.66 (+1.48%)
As of Jun 24, 8:55 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +101.2% upside
Low Target $64.19
Average Target $90.83
High Target $118.96
Current Price $45.14
Current
$45.14
Target
$90.83
$64.19 $90.83 avg $118.96
Scenario Analysis
Bear Case
$64.19
42.2%
Low target
Base Case
$90.83
+101.2%
Avg target
Bull Case
$118.96
+163.5%
High target
Risk/Reward
3.9x
Highly favorable
Price in Context
52-Week High
$59.68
-24.4% from high
52-Week Low
$30.83
+46.4% from low
50-Day SMA
$49.76
-9.3% vs SMA
200-Day SMA
$43.00
+5.0% vs SMA
RSI (14)
59.9
Neutral
Target vs 52W High
$90.83
+52.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%